USNA - USANA Health Sciences GAAP EPS of $0.66 beats by $0.31 revenue of $228M beats by $24.2M
- USANA Health Sciences press release ( NYSE: USNA ): Q4 GAAP EPS of $0.66 beats by $0.31 .
- Revenue of $228M (-14.6% Y/Y) beats by $24.2M .
- Fiscal year 2022 net sales were $999 million as compared with $1,186 million during fiscal year 2021.
- Fiscal year 2022 diluted EPS totaled $3.59 versus $5.73 during fiscal year 2021.
- Fiscal year 2022 operating cash flow totaled $104 million.
- Company reiterates fiscal year 2023 net sales and diluted EPS outlook of $850 million to $950 million and $2.35 to $3.30, respectively.
For further details see:
USANA Health Sciences GAAP EPS of $0.66 beats by $0.31, revenue of $228M beats by $24.2M